MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/12/2018
30/12/2017
30/12/2016
30/12/2015
Total revenue
45,970,000
42,294,000
40,122,000
39,807,000
39,498,000
Cost of revenue
13,732,000
13,509,000
12,775,000
13,891,000
14,934,000
Gross profit
32,238,000
28,785,000
27,347,000
25,916,000
24,564,000
Operating expenses
Research development
9,538,000
9,752,000
9,982,000
7,194,000
6,704,000
Selling general and administrative
10,369,000
10,102,000
9,830,000
9,762,000
10,313,000
Total operating expenses
19,907,000
19,854,000
19,812,000
16,956,000
17,017,000
Operating income or loss
12,331,000
8,931,000
7,535,000
8,960,000
7,547,000
Interest expense
877,000
772,000
754,000
693,000
672,000
Total other income/expenses net
-488,000
199,000
-419,000
-1,096,000
-1,763,000
Income before tax
11,277,000
8,701,000
6,747,000
7,499,000
5,401,000
Income tax expense
2,085,000
2,508,000
4,155,000
1,787,000
942,000
Income from continuing operations
9,192,000
6,193,000
2,592,000
5,712,000
4,459,000
Net income
9,314,000
6,220,000
2,568,000
5,691,000
4,442,000
Net income available to common shareholders
9,314,000
6,220,000
2,568,000
5,691,000
4,442,000
Reported EPS
Basic
-
2.40
0.95
2.07
1.60
Diluted
-
2.32
0.93
2.04
1.56
Weighted average shares outstanding
Basic
-
2,592,560
2,696,612
2,748,731
2,781,128
Diluted
-
2,679,000
2,748,000
2,787,000
2,841,000
EBITDA
-
9,473,000
7,501,000
8,192,000
6,073,000
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more